American Journal of Kidney Diseases
Volume 53, Issue 4 , Pages 579-583 , April 2009

The Genetic Basis of Kidney Disease Risk in African Americans: MYH9 as a New Candidate Gene

  • Madhumathi Rao, MD

      Affiliations

    • Corresponding Author InformationAddress correspondence to Madhumathi Rao, MD, Division of Nephrology, Tufts Medical Center, Box 391, 800 Washington St, Boston, MA 02111
    • ,
  • V.S. Balakrishnan, MD, PhD

References 

  1. Bowden DW. Genetics of kidney disease. Kidney Int Suppl. 2003;83:S8–S12
  2. Freedman BI, Spray BJ, Tuttle AB, Buckalew VM. The familial risk of end-stage renal disease in African Americans. Am J Kidney Dis. 1993;21:387–393
  3. Lei HH, Perneger TV, Klag MJ, Whelton PK, Coresh J. Familial aggregation of renal disease in a population-based case-control study. J Am Soc Nephrol. 1998;9:1270–1276
  4. Fox CS, Yang Q, Cupples LA, et al. Genomewide linkage analysis to serum creatinine, GFR, and creatinine clearance in a community-based population: The Framingham Heart Study. J Am Soc Nephrol. 2004;15:2457–2461
  5. Fox CS, Yang Q, Guo CY, et al. Genome-wide linkage analysis to urinary microalbuminuria in a community-based sample: The Framingham Heart Study. Kidney Int. 2005;67:70–74
  6. Langefeld CD, Beck SR, Bowden DW, Rich SS, Wagenknecht LE, Freedman BI. Heritability of GFR and albuminuria in Caucasians with type 2 diabetes mellitus. Am J Kidney Dis. 2004;43:796–800
  7. Leon JM, Freedman BI, Miller MB, et al. Genome scan of glomerular filtration rate and albuminuria: The HyperGEN study. Nephrol Dial Transplant. 2007;22:763–771
  8. US Renal Data System. USRDS 2006 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2006;
  9. Hajjar I, Kotchen TA. Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA. 2003;290:199–206
  10. Centers for Disease Control and Prevention. National diabetes fact sheet: General information and national estimates on diabetes in the United States, 2003. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2003;
  11. McClellan W, Tuttle E, Issa A. Racial differences in the incidence of hypertensive end-stage renal disease (ESRD) are not entirely explained by differences in the prevalence of hypertension. Am J Kidney Dis. 1988;12:285–290
  12. Brancati FL, Whittle JC, Whelton PK, Seidler AJ, Klag MJ. The excess incidence of diabetic end-stage renal disease among blacks (A population-based study of potential explanatory factors). JAMA. 1992;268:3079–3084
  13. Tarver-Carr ME, Powe NR, Eberhardt MS, et al. Excess risk of chronic kidney disease among African-American versus white subjects in the United States: A population-based study of potential explanatory factors. J Am Soc Nephrol. 2002;13:2363–2370
  14. Klag MJ, Whelton PK, Randall BL, Neaton JD, Brancati FL, Stamler J. End-stage renal disease in African-American and white men (16-year MRFIT findings). JAMA. 1997;277:1293–1298
  15. Cowie CC, Port FK, Wolfe RA, Savage PJ, Moll PP, Hawthorne VM. Disparities in incidence of diabetic end-stage renal disease according to race and type of diabetes. N Engl J Med. 1989;321:1074–1079
  16. Toto RD. Proteinuria and hypertensive nephrosclerosis in African Americans. Kidney Int Suppl. 2004;92:S102–S104
  17. Fernandez M, Alarcon GS, Calvo-Alen J, et al. A multiethnic, multicenter cohort of patients with systemic lupus erythematosus (SLE) as a model for the study of ethnic disparities in SLE. Arthritis Rheum. 2007;57:576–584
  18. Kitiyakara C, Eggers P, Kopp JB. Twenty-one-year trend in ESRD due to focal segmental glomerulosclerosis in the United States. Am J Kidney Dis. 2004;44:815–825
  19. Kopp JB, Winkler C. HIV-associated nephropathy in African Americans. Kidney Int Suppl. 2003;83:S43–S49
  20. US Renal Data System. USRDS 2008 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2008;
  21. Hsu CY, Lin F, Vittinghoff E, Shlipak MG. Racial differences in the progression from chronic renal insufficiency to end-stage renal disease in the United States. J Am Soc Nephrol. 2003;14:2902–2907
  22. Satko SG, Freedman BI, Moossavi S. Genetic factors in end-stage renal disease. Kidney Int Suppl. 2005;94:S46–S49
  23. Reiner AP, Ziv E, Lind DL, et al. Population structure, admixture, and aging-related phenotypes in African American adults: The Cardiovascular Health Study. Am J Hum Genet. 2005;76:463–477
  24. Parra EJ, Marcini A, Akey J, et al. Estimating African American admixture proportions by use of population-specific alleles. Am J Hum Genet. 1998;63:1839–1851
  25. Kao WH, Klag MJ, Meoni LA, et al. MYH9 is associated with nondiabetic end-stage renal disease in African Americans. Nat Genet. 2008;40:1185–1192
  26. Kopp JB, Smith MW, Nelson GW, et al. MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis. Nat Genet. 2008;40:1175–1184
  27. Nievergelt CM, Schork NJ. Admixture mapping as a gene discovery approach for complex human traits and diseases. Curr Hypertens Rep. 2005;7:31–37
  28. Smith MW, O'Brien SJ. Mapping by admixture linkage disequilibrium: advances, limitations and guidelines. Nat Rev Genet. 2005;6:623–632
  29. Darvasi A, Shifman S. The beauty of admixture. Nat Genet. 2005;37:118–119
  30. Sellers JR. Myosins: A diverse superfamily. Biochim Biophys Acta. 2000;1496:3–22
  31. Seri M, Pecci A, Di Bari F, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore). 2003;82:203–215
  32. Pezzolesi MG, Poznik GD, Mychaleckyj JC, et al. Genome-wide association scan for diabetic nephropathy (DN) susceptibility genes in type 1 diabetes mellitus: Results from the Genetics of Kidneys in Diabetes (GoKinD) Collection. J Am Soc Nephrol. 2008;19:57A;(abstr)
  33. Hwang SJ, Yang Q, Meigs JB, Pearce EN, Fox CS. A genome-wide association for kidney function and endocrine-related traits in the NHLBI's Framingham Heart Study. BMC Med Genet. 2007;8(suppl 1):S10
  34. Kottgen A, Kao WH, Hwang SJ, et al. Genome-wide association study for renal traits in the Framingham Heart and Atherosclerosis Risk in Communities Studies. BMC Med Genet. 2008;9:49
  35. Bowden DW, Colicigno CJ, Langefeld CD, et al. A genome scan for diabetic nephropathy in African Americans. Kidney Int. 2004;66:1517–1526
  36. Freedman BI, Langefeld CD, Rich SS, et al. A genome scan for ESRD in black families enriched for nondiabetic nephropathy. J Am Soc Nephrol. 2004;15:2719–2727
  37. Barisoni L, Schnaper HW, Kopp JB. A proposed taxonomy for the podocytopathies: A reassessment of the primary nephrotic diseases. Clin J Am Soc Nephrol. 2007;2:529–542
  38. Reich D, Patterson N. Will admixture mapping work to find disease genes?. Philos Trans R Soc Lond B Biol Sci. 2005;360:1605–1607
  39. The Family Investigation of Nephropathy and Diabetes Research Group. Genetic determinants of diabetic nephropathy: The family investigation of nephropathy and diabetes (FIND). J Am Soc Nephrol. 2003;14(suppl 2):S202–S204
  40. Freedman BI, Sedor JR. Hypertension-associated kidney disease: Perhaps no more. J Am Soc Nephrol. 2008;19:2047–2051
  41. Freedman BI, Kopp JB, Winkler CA, et al. Polymorphisms in the nonmuscle myosin heavy chain 9 gene (MYH9) are associated with albuminuria in hypertensive African Americans: The HyperGEN Study. Am J Nephrol. 2009;29:626–632
  42. Bamgboye EL. End-stage renal disease in sub-Saharan Africa. Ethn Dis. 2006;16:S2-5-9
  43. Barsoum RS. Chronic kidney disease in the developing world. N Engl J Med. 2006;354:997–999
  44. Behar DM, Shlush LI, Maor C, Lorber M, Skorecki K. Absence of HIV-associated nephropathy in Ethiopians. Am J Kidney Dis. 2006;47:88–94
  45. Taylor AL, Ziesche S, Yancy C, et al. Combination of isosorbide dinitrate and hydralazine in blacks with heart failure. N Engl J Med. 2004;351:2049–2057

PII: S0272-6386(09)00424-7

doi: 10.1053/j.ajkd.2009.02.005

American Journal of Kidney Diseases
Volume 53, Issue 4 , Pages 579-583 , April 2009

Article Tools

* Image Usage & Resolution